Search

Your search keyword '"Francolini, Giulio"' showing total 16 results

Search Constraints

Start Over You searched for: Author "Francolini, Giulio" Remove constraint Author: "Francolini, Giulio" Journal journal of clinical oncology Remove constraint Journal: journal of clinical oncology
16 results on '"Francolini, Giulio"'

Search Results

1. Apalutamide and stereotactic body radiation therapy for low-burden, metastatic, hormone-sensitive prostate cancer: A randomized trial (PERSIAN).

2. (ARTO trial-NCT03449719): Role of local treatment after progression in patients with castrate-resistant prostate cancer undergoing first-line abiraterone treatment.

3. ARTO trial: Overall survival analysis from a randomized phase II trial testing the benefit of adding stereotactic body radiotherapy to abiraterone acetate in patients with oligometastatic castrate-resistant prostate cancer.

4. Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO).

5. Early biochemical outcomes following PSMA-guided approach for biochemical relapse after prostatectomy: PSICHE trial.

6. Quality of life after radical treatment for muscle invasive bladder cancer: A systematic review and meta-analysis.

7. Salvage radiotherapy guided by functional imaging for macroscopic local recurrence following radical prostatectomy: A multicentric retrospective study.

8. ARTO trial-(NCT03449719): Early results from a phase II randomized trial testing stereotactic body radiation therapy in patients with oligometastatic castration-resistant prostate cancer undergoing I line treatment with abiraterone acetate.

9. PRIMERA trial (NCT04188275), early survival results from a prospective trial exploring impact of circulating tumor cell detection in castrate resistant prostate cancer patients undergoing abiraterone or enzalutamide I line treatment.

11. ARTO trial (NCT03449719), a randomized phase II trial enrolling oligometastatic castration-resistant prostate cancer patients treated with first-line abiraterone acetate with or without stereotactic body radiation therapy: Preliminary results comprehensive of biochemical outcomes and circulating tumor cells analysis.

12. Preliminary results of a prospective assessment of androgen receptor splice variants in mCRPC patients undergoing androgen receptor targeted agents.

13. Influence of age and histologic subtype in outcome of operable liposarcoma.

14. A matched cohort study of adjuvant radiochemotherapy versus radiotherapy alone in soft tissue sarcoma patients.

15. Multimodality treatment of synovialsarcoma: A single institution experience.

16. Management of liposarcoma: A single institutional analysis.

Catalog

Books, media, physical & digital resources